辐射和双重检查点封锁激活了癌症中的非冗余免疫机制
Christina Twyman-Saint Victor1, Andrew J Rech2, Amit Maity3
11] Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA [2] Abramson Family Cancer Research Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA.
Nature
|March 11, 2015
概括
将放射治疗与抗CTLA4和抗PD-L1/PD-1抗体相结合,对于最佳的抗癌反应至关重要. 这种组合克服了像T细胞枯竭这样的抵抗机制,增强了黑色素瘤的抗瘤免疫力.
科学领域:
- 免疫学和癌症治疗疗法
- 瘤微环境和免疫反应
背景情况:
- 免疫检查点抑制剂 (ICI) 显示出临床前景,但通常需要组合疗法以获得最佳疗效.
- 了解非冗余性和抗性的机制对于改善ICI治疗至关重要.
- 转移性黑色素瘤带来了重大治疗挑战,需要新的治疗策略.
研究的目的:
- 研究在转移性黑色素瘤中结合抗CTLA4抗体和放射治疗的疗效.
- 阐明在联合抗CTLA4和放射治疗中观察到的耐药性机制.
- 确定最佳的组合疗法,以增强抗瘤免疫反应.
主要方法:
- 临床试验涉及转移性黑色素瘤患者,接受抗CTLA4抗体和辐射治疗.
- 在小鼠模型中进行临床前研究,以复制和分析治疗效应和耐药性机制.
- 对T细胞种群,T细胞受体 (TCR) 剧目和PD-L1表达的公正分析.
主要成果:
- 结合抗CTLA4和辐射诱导患者和小鼠的一个子集显著的瘤回归.
- 耐药性与黑色素瘤细胞的PD-L1上调和T细胞耗尽有关.
- 辐射,抗CTLA4和抗PD-L1/PD-1的组合逆转了T细胞疲劳,并促进了抗瘤免疫力.
结论:
- 黑色素瘤细胞上的PD-L1表达是抗CTLA4治疗的关键逃生机制.
- 最佳的抗瘤反应需要采用多方面的方法,包括辐射,抗CTLA4和抗PD-L1/PD-1阻塞.
- 组合疗法通过不同的机制增强抗瘤免疫力:T细胞扩张,TCR谱系多样化和逆转T细胞枯竭.
相关概念视频
01:27Tumor Immunotherapy
2.5K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.5K
01:31The Intrinsic Apoptotic Pathway
9.3K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
9.3K
02:53Adaptive Mechanisms in Cancer Cells
7.6K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.6K
02:53Adaptive Mechanisms in Cancer Cells
4.3K
4.3K
02:57Targeted Cancer Therapies
9.2K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.2K
02:36DNA Damage can Stall the Cell Cycle
10.4K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
10.4K